Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_assertion type Assertion NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_head.
- NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_assertion description "[Genetic characterization of these ALK-positive tumors indicated that full-length ALK expression in two serous carcinoma patients is consistent with ALK gene copy number gain, whereas a stromal sarcoma patient carries a novel transmembrane ALK fusion gene: FN1-ALK.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_provenance.
- NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_assertion evidence source_evidence_literature NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_provenance.
- NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_assertion SIO_000772 22570254 NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_provenance.
- NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_assertion wasDerivedFrom befree-20140225 NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_provenance.
- NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_assertion wasGeneratedBy ECO_0000203 NP418154.RAE2cjjRJude-mSkqPHu569oebeo5q3CSlBwscD5t_UF4130_provenance.